Sumi Sukanya Dutta

Without fixing funding in healthcare, improving training quality, and accountability, relicensing risks becoming another box-ticking exercise.

Tax relief for select cancer drugs offers hope, but broader health spending stays anaemic.

Health spending isn't just about budgets—it results in how long, and how well, people live.

Breakthrough studies in mice and early human trials are reviving hope against one of the deadliest cancers.

The study strengthens the case for AI as a clinical ally—one that could reshape breast cancer screening worldwide.

The report calls screen addiction among children and adolescents a growing public health risk.

For India's young adults, rising blood pressure is no longer just a lifestyle problem—it may be a warning sign of deeper disease.

Despite regional leadership ambitions, India continues to underinvest in the health of its own people.

A painkiller meant for relief now faces tighter scrutiny as abuse concerns spill into policy.

Five years after Covid, India's health system still waits for its moment in the budget spotlight.